MGC Pharmaceuticals Receives approvals for South Africa CimetrA trial
MGC Pharmaceuticals (MXC) receives study and import approvals from the South African Health Products Regulatory...
MGC Pharmaceuticals Completes glioblastoma study
MGC Pharmaceuticals (MXC) completes a successful in-vitro preclinical research study in the use of cannabinoids to treat glioblastoma
The...
MGC Pharmaceuticals Receives $4m purchase order
MGC Pharmaceuticals (MXC) receives an order for more than $4 million for its COVID-19 treatment, CimetrA
The order...
MGC Pharmaceuticals: Expands Phase IIb trial for COVID-19 patients to India
MGC Pharmaceuticals will expand its Phase IIb clinical trial of ArtemiC in COVID-19...
